Employees: 03 (2023.0)Legal category: 5485Size: PMECreation date: 2010-01-06 (16 years)Status: ActiveBusiness sector: Commerce de détail de produits pharmaceutiques en magasin spécialiséLocation: ABBEVILLE (80100), Somme
PHARMACIE DE LA SUCRERIE : revenue, balance sheet and financial ratios
PHARMACIE DE LA SUCRERIE is a French company
founded 16 years ago,
specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé.
Based in ABBEVILLE (80100),
this company of category PME
shows in 2023 a revenue of 3.0 M€.
Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Financial history - PHARMACIE DE LA SUCRERIE (SIREN 519462006)
Indicator
2025
2024
2023
2022
2021
2020
2019
2018
2017
Revenue
N/C
N/C
2 983 120 €
2 909 684 €
2 546 772 €
2 517 385 €
2 247 836 €
1 681 982 €
1 640 928 €
Net income
150 619 €
97 865 €
202 711 €
328 556 €
179 490 €
212 709 €
157 073 €
124 429 €
133 636 €
EBITDA
N/C
N/C
333 550 €
502 813 €
302 475 €
353 116 €
269 652 €
233 474 €
211 396 €
Net margin
N/C
N/C
6.8%
11.3%
7.0%
8.4%
7.0%
7.4%
8.1%
Revenue and income statement
In 2025, PHARMACIE DE LA SUCRERIE generates positive net income of 151 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2017-2025: 134 k€ -> 151 k€.
Net income (2025)
?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax
150 619 €
Loading income statement...
Income statement
Item
Amount
% Revenue
Change
The detailed income statement is not available for this company (simplified accounts or confidential data).
Chart evolution
Show :
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Assets
Loading data...
Item
Gross
Deprec.
Net
%
Change
Assets balance sheet data not available for this company
Liabilities
Loading data...
Item
Year
%
Change
Liabilities balance sheet data not available for this company
Solvency and debt ratios
The debt ratio (= Financial debt / Equity x 100) stands at 1%. This very low level reflects a solid financial structure, offering significant room for future investments or acquisitions. Financial autonomy (= Equity / Total assets x 100) reaches 84%. This high autonomy means the company finances most of its assets through equity, a sign of strength.
Debt ratio (2025)
?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low 50-100% : Moderate > 100% : High
0.515%
Financial autonomy (2025)
?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy 20-30% : Average < 20% : Low
83.86%
Asset age ratio (2025)
?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Solvency indicators evolution PHARMACIE DE LA SUCRERIE
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2017
2018
2019
2020
2021
2022
2023
2024
2025
Debt ratio
93.704
98.115
82.593
59.165
42.923
25.288
10.935
5.998
0.515
Financial autonomy
48.453
44.025
48.039
54.953
61.802
68.132
78.597
80.854
83.86
Repayment capacity
7.711
8.914
5.199
3.323
3.053
1.299
0.878
None
None
Cash flow / Revenue
7.983%
7.731%
9.282%
10.695%
9.197%
13.245%
9.004%
None%
None%
Sector positioning
Debt ratio
0.522025
2023
2024
2025
Q1: 13.7
Med: 49.79
Q3: 129.09
Excellent
In 2025, the debt ratio of PHARMACIE DE LA SUCRERIE (0.52) ranks in the bottom 25% of the sector, which is positive. This ratio measures the weight of debt relative to equity. A low ratio indicates a solid financial structure with little dependence on creditors.
Financial autonomy
83.86%2025
2023
2024
2025
Q1: 33.42%
Med: 53.72%
Q3: 72.08%
Excellent+9 pts over 3 years
In 2025, the financial autonomy of PHARMACIE DE LA SUCRERIE (83.9%) ranks in the top 25% of the sector. This ratio represents the share of equity in total financing. High autonomy reflects financial independence and ability to absorb shocks.
Repayment capacity
0.88 years2023
2023
Q1: 0.95 years
Med: 3.59 years
Q3: 7.48 years
Excellent
In 2023, the repayment capacity of PHARMACIE DE LA SUCRERIE (0.88) ranks in the bottom 25% of the sector, which is positive. This ratio indicates the number of years needed to repay debt with cash flow. A short capacity reflects controlled debt and good cash generation.
Liquidity ratios
The liquidity ratio (= Current assets / Current liabilities) stands at 117.05. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.
Liquidity ratio (2025)
?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good 1-1.5 : Fair < 1 : Liquidity risk
117.053
Liquidity indicators evolution PHARMACIE DE LA SUCRERIE
Visualisation créée via abddaf.fr Sources : INPI & BCE - Retraitements : Ministère de l'économie
Indicator
2017
2018
2019
2020
2021
2022
2023
2024
2025
Liquidity ratio
299.732
127.686
136.59
151.828
164.16
184.087
189.504
187.874
117.053
Interest coverage
11.861
25.267
4.196
2.503
2.355
1.158
1.069
None
None
Sector positioning
Liquidity ratio
117.052025
2023
2024
2025
Q1: 131.03
Med: 182.25
Q3: 258.64
Watch-27 pts over 3 years
In 2025, the liquidity ratio of PHARMACIE DE LA SUCRERIE (117.05) ranks in the bottom 25% of the sector. This ratio measures the ability to cover short-term debt with current assets. A ratio below 1 may signal potential cash flow tensions.
Interest coverage
1.07x2023
2023
Q1: 0.38x
Med: 2.71x
Q3: 6.47x
Average
In 2023, the interest coverage of PHARMACIE DE LA SUCRERIE (1.1x) ranks below the median of the sector. This ratio indicates how many times operating income covers interest expenses. An improvement would strengthen the competitive position.
Working capital requirement (WCR) and payment terms
Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments.
Operating WCR (2025)
?
Operating WCR
Definition
Financing requirement generated by the operating cycle (inventory + receivables - trade payables).
Formula
Inventory + Customer receivables - Trade payables
Interpretation
Negative = cash released Positive = financing needed
0 €
Customer credit (2025)
?
Customer credit (days)
Definition
Average payment term granted to customers.
Formula
(Customer receivables / Revenue incl. VAT) x 360
Interpretation
< 45j : Good 45-60j : Average > 60j : Long
0 j
Supplier credit (2025)
?
Supplier credit (days)
Definition
Average payment term obtained from suppliers.
Formula
(Trade payables / Purchases incl. VAT) x 360
Interpretation
The longer the term, the better for cash flow
0 j
Inventory turnover (2025)
?
Inventory turnover (days)
Definition
Average storage duration for goods or materials.
Formula
(Inventory / Cost of goods) x 360
Interpretation
The lower the ratio, the faster the turnover
0 j
WCR and payment terms evolution PHARMACIE DE LA SUCRERIE
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2017
2018
2019
2020
2021
2022
2023
2024
2025
Operating WCR
268 243 €
345 832 €
367 184 €
354 775 €
392 891 €
417 598 €
439 951 €
0 €
0 €
Inventory turnover (days)
31
38
36
37
37
34
35
0
0
Customer payment term (days)
11
11
7
5
6
8
6
0
0
Supplier payment term (days)
25
79
53
49
45
53
43
0
0
Positioning of PHARMACIE DE LA SUCRERIE in its sector
Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé
Valuation estimate
Based on 277 transactions of similar company sales
in 2025,
the value of PHARMACIE DE LA SUCRERIE is estimated at
2 392 600 €
(range 1 623 630€ - 3 754 320€).
This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Estimated enterprise value2025
277 transactions
1623k€2392k€3754k€
2 392 600 €Range: 1 623 630€ - 3 754 320€
NAF 5 année 2025
Valuation method used
Net Income Multiple
150 619 €
×
15.9x
=2 392 601 €
Range: 1 623 630€ - 3 754 320€
Only this financial indicator is available for this company.
Valuation evolution
Visualisation creee via abddaf.fr Sources : BODACC & INPI
How is this estimate calculated?
This estimate is based on the analysis of 277 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
Net Income Multiple: Relevant for mature companies with stable results.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)
Compare PHARMACIE DE LA SUCRERIE with other companies in the same sector:
Frequently asked questions about PHARMACIE DE LA SUCRERIE
What is the revenue of PHARMACIE DE LA SUCRERIE ?
The revenue of PHARMACIE DE LA SUCRERIE in 2023 is 3.0 M€.
Is PHARMACIE DE LA SUCRERIE profitable?
Yes, PHARMACIE DE LA SUCRERIE generated a net profit of 151 k€ in 2025.
Where is the headquarters of PHARMACIE DE LA SUCRERIE ?
The headquarters of PHARMACIE DE LA SUCRERIE is located in ABBEVILLE (80100), in the department Somme.
Where to find the tax return of PHARMACIE DE LA SUCRERIE ?
The tax return of PHARMACIE DE LA SUCRERIE is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
In which sector does PHARMACIE DE LA SUCRERIE operate?
PHARMACIE DE LA SUCRERIE operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.
Item evolution
Rotate your phone to landscape mode to view the chart